Two studies have shown that over 60% of SCLC tumors are positive for B7-H3 staining, with B7-H3 expression occurring significantly more frequently than PD-L1 expression, which ranges from 7% to 13% in SCLC cases [127,128]. This evidence concerns the gene CD276 and small cell lung carcinoma.